期刊文献+

急性髓系白血病患者外周血CD4^+CD25^highFOXP3^+调节性T细胞变化及临床意义 被引量:4

Changes of CD4^+CD25^(high)FOXP3^+ regulatory T cells in peripheral blood of patients with acute myelogenous leukemia and its clinical significances
下载PDF
导出
摘要 目的:观察急性髓系白血病(Acute myelogenous leukemia,AML)患者外周血中调节性T细胞(Regulatory Tcells,Treg细胞)的变化,探讨其在AML发病中的作用及临床意义。方法:应用流式细胞术检测31例初诊AML患者(初诊组)、23例经化疗取得完全缓解患者(CR组)及20例健康人群(对照组)外周血CD4+CD25highFOXP3+Treg细胞、CD4+FOXP3+T细胞占CD4+细胞的比例,同时还分析了外周血CD4+/CD8+比值、NK细胞及血清乳酸脱清酶(LDH)水平。结果:与对照组相比较,AML患者初诊组及CR组外周血CD4+CD25highFOXP3+Treg细胞和CD4+FOXP3+T细胞均升高(P<0.01)。与初诊组相比较,CR组CD4+CD25highFOXP3+Treg细胞无显著降低(P>0.05),CD4+FOXP3+T细胞明显下降(P<0.01)。CD4+CD25highFOXP3+Treg细胞的升降与CD4+FOXP3+T细胞呈正相关(r=0.86;P<0.01)。CD4+CD25highFOXP3+Treg细胞及CD4+FOXP3+T细胞比例与CD4+/CD8+比值呈负相关(r分别为-0.54、-0.52;P<0.01)、与NK细胞比例呈负相关(r分别为-0.41、-0.43;P<0.05),而与LDH水平呈正相关(r分别为0.51、0.57;P<0.05)。结论:CD4+CD25highFOXP3+Treg细胞增多可能是AML患者免疫功能受抑的重要原因之一,其变化对于AML的预后判断有一定的意义。CD4+FOXP3+T细胞的作用类似于CD4+CD25highFOXP3+Treg细胞,其在AML疗效评价方面可能更有价值。 Objective: To observe the changes of CD4^+CD25^highFOXP3^+ regulatory T cells (Treg cells) in peripheral blood of patients with acute myelogenous leukemia (AML) in order to reveal the role of Treg cells in the pathogenesis of AML and to evaluate its clinical significance.Methods:The flow cytometry was used to evaluate the proportion of CD4^+CD25^highFOXP3^+ Treg cells and CD4^+ FOXP3^+ T cells in the peripheral blood of 31 patients with AML who were newly diagnosed ( newly diagnosed group), 23 patients with AML who achieved complete remission (CR group) and 20 healthy donors (control group). CD^4+ +/CD8^+ ratio, the proportion of NK cells and the level of lactate dehydrogenase (LDH) were also analyzed. Results:Compared with that of control group,the proportion of CD4^+CD25^highFOXP3^+ Treg cells and CD4^+ FOXP3^+ T cells in newly diagnosed group were significantly increased ( P 〈 0.01 ). Compared with that of the newly diagnosed group,the proportion of CD4^+CD25^highFOXP3^+ Treg cells in CR group was not significantly decreased ( P 〉 0.05), while that of CD4^+ FOXP3^+ T cells was decreased ( P 〈 0. 01 ). The proportion of CD4^+CD25^highFOXP3^+ Treg cells was positively correlated with the proportion of CD4^+ FOXP3^+ T cells (r = 0.86; P 〈 0.01 ). The proportion of CD4^+CD25^highFOXP3^+ Treg cells and CD4^+ FOXP3^+ T cells was negatively correlated with CD4^+/CD8 + ratio( r = - 0.54, - 0.52, respectively; P 〈 0.01 ) and the proportion of NK cells ( r = - 0.41, - 0. 43, respectively; P 〈0. 05), positively correlated with the level of LDH ( r = 0.51,0.57, respectively; P 〈 0.05 ). Conclusion: The increased number of CD4^+CD25^highFOXP3^+Treg cells might be one of the important reasons of immunosuppression in AML. Analysis of its changes may be helpful on judgement of prognosis of AML. The function of CD4^+ FOXP3^+ Treg cells is similar to CD4^+CD25^highFOXP3^+ Treg cells. Measurement of its proportion may be more value on evaluation of therapeutic effect.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2009年第7期591-595,600,共6页 Chinese Journal of Immunology
基金 国家自然科学基金资助项目(30671984) 镇江市社会发展项目(SH2006031)
关键词 T淋巴细胞 调节性 白血病 非淋巴细胞 急性 流式细胞术 T lymphocytes Regulatory Leukemia Nonlymphocytic Acute Flow cytometry
  • 相关文献

参考文献1

二级参考文献9

  • 1Nekulova M,Simickova M,Pecen L,et al.Early diagnosis of breast cancer dissemination by tumor markers follow-up and method of prediction[J].Neoplasma,1994,41 (2):113 -118.
  • 2Ahn MJ,Park CK,Choi JH,et al.Clinical significance of microvessel density in multiple myeloma patients[J].J Korean Med Sci,2001,16(1):45 -50.
  • 3Merlini G,Baldini L,Broglia C,et al.Prognostic factors in symptomatic Waldenstrom's macroglobulinemia[J].Semin Oncol,2003,30(2):211 -215.
  • 4Onida F,Kantarjian HM,Smith TL,et al.Prognostic factors and scoring systems in chronic myelomonocytic leukemia:a retrospective analysis of 213 patients[ J].Blood,2002,99 (3):840-849.
  • 5Jordanova ES,Riemersma SA,Philippo K,et al.Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system[ J].Int J Cancer,2003,103 (3):393 -398.
  • 6Chronowski GM,Wilder RB,Tucker SL,et al.An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease[J].Cancer,2002,95 (12):2534-2538.
  • 7孙碧红,蓝梅,杜武杰.S-LDH和Sβ_2-MG判断白血病患者预后的意义[J].广西医科大学学报,2002,19(2):198-200. 被引量:13
  • 8魏延波,杨文东,石红桥.血液病患者血清乳酸脱氢酶水平变化及临床意义[J].上海医学检验杂志,2003,18(1):8-8. 被引量:18
  • 9何晖,翟明,刘丽君.NHL患者血清β_2-MG和LDH水平与骨髓浸润的相关性研究[J].白血病.淋巴瘤,2003,12(1):18-20. 被引量:17

共引文献5

同被引文献60

  • 1Ye, Zhou,Wang, Yan,Xie, Hai-Yang,Zheng, Shu-Sen.Immunosuppressive effects of rat mesenchymal stem cells:involvement of CD4^+ CD25^+ regulatory T cells[J].Hepatobiliary & Pancreatic Diseases International,2008,7(6):608-614. 被引量:15
  • 2Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance[J]. Cell, 2000,101 (5) : 455-458.
  • 3Aggarwal S, Gumey AL. IL-17: prototype member of an emerging cytokine family[J]. J Leukoc Biol, 2002,71 (1) : 1-8.
  • 4Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4^+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J]. Nat Immunol, 2005,6(11) : 1123-1132.
  • 5IWakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation[J]. J Clin Invest,2006,116(5) : 1218-1222.
  • 6Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases [J]. J Immunol, 1995,155(3) : 1151-1164.
  • 7Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients[J]. Clin Cancer Res, 2003,9 (2) : 606-612.
  • 8Beyer M, Kochanek M, Darabi K, et al. Reduced frequencies and suppressive function of CD4^+ CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fudarabine[J]. Blood, 2005,106 (6) : 2018-2025.
  • 9Wang X, Zheng J, Liu J, et al. Increased population of CIM (+) CD25 (high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients[J]. Eur J Haematol, 2005,75 (6) : 468- 476.
  • 10MeKenzie BS, Kastelein RA, Cua DJ. Understanding the IL-23-IL-17 immune pathway[J]. Trends Immnuol, 2006,27 (1) : 17-23.

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部